Pharmaceutical formulations comprising sodium amoxycillin and potassium clavulanate
OwnerMalcolm Dashinventor
Life of this patent
Estimating the term…
Abstract
A tablet formulation comprising amoxycillin and potassium clavulanate, in a weight ratio amoxycillin:clavulanate between 1:1 to 20:1 (expressed as the weight of the corresponding parent acids) inclusive, wherein the amoxycillin is sodium amoxycillin or a mixture of sodium amoxycillin and amoxycillin trihydrate and the tablet has an enteric film coating is of use in treating bacterial infection.
Claims15
A tablet formulation comprising amoxycillin and potassium clavulanate, in a weight ratio amoxycillin:
- clavulanate between 1:1 to 20:1 (expressed as the weight of the corresponding parent acids) inclusive, wherein the amoxycillin is sodium amoxycillin or a mixture of sodium amoxycillin and amoxycillin trihydrate and the tablet has an enteric film coating.
A tablet formulation according to any one of the preceding claims comprising nominally 125/62.5, 250/62.5, 250/125, 500/62.5, 500/125, 875/125, 1000/62.5 and 1000/125 mg amoxycillin/clavulanate.
A tablet formulation comprising amoxycillin wherein the amoxycillin is sodium amoxycillin and optionally amoxycillin trihydrate and the tablet has an enteric film coating.
Dependencies are inferred from the claim text.